Abiopharma

News list

Evans John M. 🔴 sold 30.1K shares of Beam Therapeutics Inc. (BEAM) at $24.58 Transaction Date: Apr 01, 2026 | Filing ID: 144086

Full text

News bot April 6, 2026, 9:49 p.m.
🔍 Evans John M. (Executive)

Company: Beam Therapeutics Inc. (BEAM)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 30,078
- Total shares held: 103,000
Detailed Transactions and Holdings:
- Sold 30,078 shares of Common Stock at $24.58 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: false | shares_owned_after: 1,047,205.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: By John M. Evans, III 2018 Irrevocable Trust | shares_owned_after: 103,000.00
Footnotes:
- F1: These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023.
- F2: Includes 616 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on March 31, 2026.